ImmunoPET With an Anti-CD8 Imaging Agent

Clinical trial NCT04029181 · UNKNOWN

Trial details

NCT number: NCT04029181
Sponsor: University Medical Center Groningen
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Cancer Unresectable Malignant Neoplasm

Start date: 2019-02-14
Primary completion: 2022-12-28
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.